These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2597202)

  • 1. Interaction of D, L-erythro- and D,L-threo-gamma-fluoromethotrexate with human leukemia cell dihydrofolate reductase.
    McGuire JJ; Haile WH; Coward JK
    Biochem Pharmacol; 1989 Dec; 38(23):4321-5. PubMed ID: 2597202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and growth inhibitory effects of the erythro and threo isomers of gamma-fluoromethotrexate, a methotrexate analogue defective in polyglutamylation.
    McGuire JJ; Graber M; Licato N; Vincenz C; Coward JK; Nimec Z; Galivan J
    Cancer Res; 1989 Aug; 49(16):4517-25. PubMed ID: 2472880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates.
    Galivan J; Inglese J; McGuire JJ; Nimec Z; Coward JK
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2598-602. PubMed ID: 2581252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence study of substrate and inhibitor binding to bovine liver dihydrofolate reductase.
    Degan P; Carpano P; Cercignani G; Montagnoli G
    Int J Biochem; 1989; 21(3):291-5. PubMed ID: 2744204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid.
    Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK
    J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (gamma-glutamate) metabolites.
    McGuire JJ; Hart BP; Haile WH; Magee KJ; Rhee M; Bolanowska WE; Russell C; Galivan J; Paul B; Coward JK
    Biochem Pharmacol; 1996 Oct; 52(8):1295-303. PubMed ID: 8937438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
    Seither RL; Rape TJ; Goldman ID
    Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biological properties of methotrexate analogs containing D-glutamic acid or D-erythro, threo-4-fluoroglutamic acid.
    McGuire JJ; Bolanowska WE; Coward JK; Sherwood RF; Russell CA; Felschow DM
    Biochem Pharmacol; 1991 Nov; 42(12):2400-3. PubMed ID: 1684899
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate analogues-27. Dual inhibition of dihydrofolate reductase and folylpolyglutamate synthetase by methotrexate and aminopterin analogues with a gamma-phosphonate group in the side chain.
    Rosowsky A; Moran RC; Forsch RA; Radike-Smith M; Colman PD; Wick MM; Freisheim JH
    Biochem Pharmacol; 1986 Oct; 35(19):3327-33. PubMed ID: 3768024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
    Fabre G; Goldman ID
    Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate analogues. 21. Divergent influence of alkyl chain length on the dihydrofolate reductase affinity and cytotoxicity of methotrexate monoesters.
    Rosowsky A; Forsch RA; Yu CS; Lazarus H; Beardsley GP
    J Med Chem; 1984 May; 27(5):605-9. PubMed ID: 6585550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of methotrexate metabolites with beef liver dihydrofolate reductase-I. Binary complex study.
    Chauvet M; Bourdeaux M; Briand C; Dell'Amico M; Gilli R; Diarra M
    Biochem Pharmacol; 1983 Mar; 32(6):1059-62. PubMed ID: 6838652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.